iHuman acquires two education apps for $13M

iHuman Inc. acquires All Knowledge and Perfect Lingo education apps for RMB94 million, appoints new executives.

ByMia Lopez- Senior Editor

Today / 16:31|Last updated: Today / 16:32

iHuman acquires two education apps for $13M — Photo: Prepared by Bond.az

iHuman Inc. (NYSE:IH) announced it has entered into agreements to acquire All Knowledge and Perfect Lingo for a total of RMB94 million (approx. $13 million).

All Knowledge focuses on humanities and AI literacy, while Perfect Lingo is an AI-powered language learning app.

The company will pay RMB67 million for All Knowledge and RMB27 million for Perfect Lingo, with possible adjustments. Additional earn-out payments may reach RMB29 million and RMB12 million respectively.

iHuman also appointed Teng Li as Co-CEO and Congyu Lin as Chief Strategy Officer. The deal was approved by the board.

More News

Revolution Medicines Phase 3 Trial Results

Today / 13:02

563

Revolution Medicines Phase 3 Trial Results

Revolution Medicines announces positive Phase 3 trial results for daraxonrasib in pancreatic cancer, showing significant survival benefit.

COMPANY →

Prostate cancer death risk cut by 20% with J&J drug

Today / 13:01

802

Prostate cancer death risk cut by 20% with J&J drug

Johnson & Johnson's apalutamide reduces prostate cancer death risk by 20%, according to Phase 3 trial results.

COMPANY →

Today / 12:31

392

Brenetafusp Shows Promise in Melanoma

Immunocore's brenetafusp showed 14.3-month median overall survival in Phase 1/2 melanoma trial, supporting Phase 3 development.

COMPANY →

Today / 09:32

611

National Vision Q1 2026: margins expand

National Vision Holdings Q1 2026 financial results: revenue $543.9M, margin expansion, 4.5% comparable store sales growth.

COMPANY →

Mineralys Presents Lorundrostat Data in Kidney Patients

Yesterday / 15:31

753

Mineralys Presents Lorundrostat Data in Kidney Patients

Mineralys (MLYS) reveals new clinical data for lorundrostat showing efficacy in hypertensive patients with chronic kidney disease.

COMPANY →

Cabometyx Cuts Neuroendocrine Tumor Risk

Yesterday / 14:31

541

Cabometyx Cuts Neuroendocrine Tumor Risk

Exelixis announces Cabometyx reduces neuroendocrine tumor progression risk by 74% in CABINET trial. New data presented at ASCO.

COMPANY →

Immunome presents phase 3 trial results for desmoid tumor drug

Yesterday / 12:32

339

Immunome presents phase 3 trial results for desmoid tumor drug

Immunome announces phase 3 results for varegacestat in desmoid tumors: 84% reduction in progression risk, 56% objective response rate.

COMPANY →

Tesla Faces China Lawsuit Over Full Self-Driving Claims

Yesterday / 07:30

735

Tesla Faces China Lawsuit Over Full Self-Driving Claims

Tesla faces a consumer lawsuit in China over Full Self-Driving claims. 10 vehicle owners allege misleading advertising and fraud, seeking $583,000 in damages.

COMPANY →

FCPT to Buy 102 Vet Properties for $268M

Yesterday / 03:02

322

FCPT to Buy 102 Vet Properties for $268M

Four Corners Property Trust acquires 102 veterinary properties for $268 million. The deal is expected to close in early Q3 2026.

COMPANY →

Yesterday / 03:00

329

Jefferies Starts Merck KGaA at Hold

Jefferies starts Merck KGaA at Hold with a €129 price target, citing balanced valuation and limited upside.

COMPANY →

Morgan Stanley stock hits all-time high of 208.01 USD

2026-05-29 20:05

327

Morgan Stanley stock hits all-time high of 208.01 USD

Morgan Stanley stock hits all-time high of 208.01 USD. 62.11% yearly gain, strong earnings, crypto trading on ETrade. Get insights on Bond.az.

COMPANY →

K92 Mining Elects Michael Carew to Board

2026-05-29 20:04

225

K92 Mining Elects Michael Carew to Board

K92 Mining elects Michael Carew to its board of directors. Carew brings 25+ years of mining experience and will serve on key committees.

COMPANY →

...